The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): Association with outcomes and evolution with therapy.
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Argos Therapeutics; Bayer; Genentech; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options/NCCN
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Onyx (Inst)
Other Relationship - Boehringer Ingelheim
 
Rebecca J Nagy
Employment - Guardant Health
Leadership - Guardant Health
 
A. Oliver Sartor
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Celgene; Johnson & Johnson; Medivation; Oncogenex; Sanofi; Tokai Pharmaceuticals
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Johnson & Johnson (Inst); Sanofi (Inst)
 
Gregory Russell Pond
No Relationships to Disclose
 
Theodore Stewart Gourdin
No Relationships to Disclose
 
Lakshminarayanan Nandagopal
No Relationships to Disclose
 
Elisa M. Ledet
No Relationships to Disclose
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Emma Carroll
No Relationships to Disclose
 
Gurudatta Naik
No Relationships to Disclose
 
Jue Wang
No Relationships to Disclose
 
Mehmet Asim Bilen
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - Bayer; Dendreon; Genentech
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
AmirAli Talasaz
Employment - Guardant Health
Leadership - Guardant Health
 
Michael B. Lilly
No Relationships to Disclose